Loading...

CellSource Co., Ltd.

4880.T•JPX
Healthcare
Biotechnology
¥736.00
¥54.00(7.92%)

CellSource Co., Ltd. (4880.T) Stock Overview

Explore CellSource Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.5/100

Key Financials

Market Cap14.6B
P/E Ratio300.14
EPS (TTM)$-2.55
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$722.96
1 Month$890.97
3 Months$1058.76
1 Year Target$652.95

4880.T Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CellSource Co., Ltd. (4880.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $652.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 300.14 and a market capitalization of 14.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

66.71RSI (14)
3.48MACD
24.63ADX
Revenue Growth
-3.45%
↓ 3.45%
Profit Growth
¥2.45
↓ 74.22%
EPS Growth
¥2.45
↓ 75.43%
Operating Margin
-3.45%
↓ 89.43%
ROE
0.80%
↓ 74.22%
Dividend Yield
0.00%
↓ 0.61%
Analyst Recommendations data is not available for 4880.TAnalyst Recommendations details for 4880.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

CEO

Takashi Sawada

Employees

151

Headquarters

Shibuya Mitake Building, Tokyo

Founded

2019

Frequently Asked Questions

;